UBS Group’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-3,800
Closed -$66.2K – 10603
2024
Q4
$66.2K Sell
3,800
-10,000
-72% -$176K ﹤0.01% 7124
2024
Q3
$242K Buy
+13,800
New +$235K ﹤0.01% 5732

Other funds holding PLSE

UBS Group's PLSE Position: Q3 2026 in Review

UBS Group reduced its Pulse Biosciences (PLSE) stake by 72% in Q3 2026, selling an estimated $8.34M and leaving 78,016 shares worth $3.89M. The position accounts for ﹤0.01% of the portfolio, ranked #4358.

UBS Group first reported a position in PLSE in Q2 2016 and has held it in 38 quarters since. The position peaked at $7.64M in Q2 2026. 142 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

  • UBS Group held 78,016 shares of Pulse Biosciences worth $3.89M as of Q3 2026.
  • UBS Group sold 197,653 Pulse Biosciences shares in Q3 2026, an estimated $8.34M.
  • Pulse Biosciences made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #4358 holding.
  • UBS Group first reported a position in Pulse Biosciences in Q2 2016 and has held it in 38 quarters since.
  • UBS Group's Pulse Biosciences position peaked at $7.64M in Q2 2026.
  • 142 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.